Citigroup Inc. trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 37.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 85,570 shares of the company’s stock after selling 52,054 shares during the period. Citigroup Inc. owned 0.10% of HealthEquity worth $8,109,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. True Wealth Design LLC boosted its position in shares of HealthEquity by 3,522.2% in the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after buying an additional 317 shares during the period. Farther Finance Advisors LLC boosted its position in HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after acquiring an additional 146 shares during the period. AlphaQuest LLC boosted its position in HealthEquity by 52.2% during the 3rd quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after acquiring an additional 214 shares during the period. Allworth Financial LP grew its stake in HealthEquity by 283.1% during the 2nd quarter. Allworth Financial LP now owns 747 shares of the company’s stock valued at $78,000 after acquiring an additional 552 shares in the last quarter. Finally, Huntington National Bank increased its holdings in shares of HealthEquity by 119.3% in the 2nd quarter. Huntington National Bank now owns 750 shares of the company’s stock valued at $79,000 after purchasing an additional 408 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Insider Buying and Selling at HealthEquity
In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.50% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Stock Report on HQY
HealthEquity Stock Down 1.2%
Shares of HQY stock opened at $76.49 on Monday. The stock’s 50 day simple moving average is $84.61 and its 200 day simple moving average is $91.13. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $116.65. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The company has a market capitalization of $6.54 billion, a price-to-earnings ratio of 35.09, a PEG ratio of 0.95 and a beta of 0.26.
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same quarter last year, the company posted $0.78 earnings per share. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
